The Pharmaceutical Research and Manufacturers of America (PhRMA) has launched Innovation Hub at www.innovation.org, which provides PhRMA resources related to the research and development process, the biopharmaceutical pipeline, and progress fighting various diseases. Learn more.
Pharmaceutical companies, Lundbeck and ACADIA, announced advancements in getting new drugs that treat people with Parkinson’s on the market, while Teva announced a recall affecting a generic Parkinson’s drug. Learn more.
(WASHINGTON, August 22, 2014) – Ronald H. Galowich, chair, and the Parkinson’s Action Network (PAN) Board of Directors announce that Ted Thompson has been selected as its next chief executive officer. He will start on September 8, 2014. Learn more.
On August 15, 2014, PAN joined 38 national organizations representing all ages and disabilities in supporting the Lifespan Respite Care Reauthorization Act (H.R. 4683) and the Military and Veteran Caregiver Services Improvement Act of 2014 (H.R. 4892). Both bills, led by Representative Jim Langevin (D-RI), reauthorize the Lifespan Respite Care Program for $15 million a year for five years. Learn more.